Skip to main content
. 2021 Mar 29;41(12):3069–3076. doi: 10.1016/j.clnu.2021.03.033

Table 3.

ICU outcomes, complications, interventions of patients by presence of feeding intolerance.a

Feeding intolerance
(N = 180)
No feeding intolerance
(N = 143)
p-value
Outcomes
 Length of ICU admission, median (IQR), days 21.5 (14–30) 15 (9–22) <0.001
 ICU readmissionb 13 (7.2) 8 (5.6) 0.65
 Length of overall hospitalization, median (IQR), days 30.5 (19–42) 24 (15–35) <0.001
 Died 61 (33.9) 23 (16.1) <0.001
COVID-19 associated complications
 Myocardial injury 86 (47.8) 19 (13.3) <0.001
 VF/VT 13 (7.2) 25 (17.5) <0.01
 AKI 143 (79.4) 83 (58.0) <0.001
 Kidney failure requiring RRT 63 (35.0) 21 (14.7) <0.001
 Acute liver injury 96 (53.3) 31 (21.7) <0.001
 Septic shock 120 (66.7) 92 (64.3) 0.72
 Coagulopathy or hypercoagulable state 91 (50.6) 37 (25.9) <0.001
GI complications
 Mesenteric ischemia 4 (2.2) 1 (0.7) 0.39
 Ischemic colitis 9 (5.0) 0 (0) <0.01
 C. diff infection 6 (3.3) 2 (1.4) 0.31
 Need for operative exploration/surgery 10 (5.6) 6 (4.2) 0.62
 Need for GI tract resection 9 (5.0) 4 (2.8) 0.40
ICU interventions
 Mechanical ventilation 179 (99.4) 142 (99.3) 1
 Length of intubation, median (IQR), daysc 19 (13.5–28.0) 13 (7.5–18.8) <0.001
 Tracheostomy 71 (39.4) 41 (28.7) 0.05
 ECMO 12 (6.7) 6 (4.2) 0.46
 Proning 150 (83.3) 91 (63.6) <0.001

Abbreviations: ICU, intensive care unit; IQR, interquartile range; VF/VT, ventricular fibrillation/ventricular tachycardia; AKI, acute kidney injury; RRT, renal replacement therapy; ECMO, extracorporeal membrane oxygenation.

a

Data are shown as number (percentage) unless otherwise noted. Percentages are rounded.

b

Defined as the number of patients who were re-admitted to the ICU during the same or a subsequent hospitalization within the study period.

c

There was 1 patient from the feeding intolerance group and 1 patient from the no feeding intolerance group who were not intubated and who were not included in this analysis.